SC
DGX icon

Syon Capital’s Quest Diagnostics DGX Stock Holding History

Syon Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562K Sell
2,867
-1,200
-30% -$233K 0.03% 508
2025
Q4 		$706K Buy
4,067
+836
+26% +$152K 0.04% 425
2025
Q3 		$616K Buy
3,231
+1,786
+124% +$317K 0.03% 413
2025
Q2 		$260K Buy
1,445
+54
+4% +$9.38K 0.02% 600
2025
Q1 		$235K Buy
+1,391
New +$229K 0.02% 497

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Syon Capital's DGX Position: Q1 2026 in Review

Syon Capital reduced its Quest Diagnostics (DGX) stake by 30% in Q1 2026, selling an estimated $233K and leaving 2,867 shares worth $562K. The position accounts for 0.03% of the portfolio, ranked #508.

Syon Capital first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. The position peaked at $706K in Q4 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Syon Capital held 2,867 shares of Quest Diagnostics worth $562K as of Q1 2026.
  • Syon Capital sold 1,200 Quest Diagnostics shares in Q1 2026, an estimated $233K.
  • Quest Diagnostics made up 0.03% of Syon Capital's portfolio in Q1 2026, its #508 holding.
  • Syon Capital first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • Syon Capital's Quest Diagnostics position peaked at $706K in Q4 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.